Education
About Us
Working with TipRanks
Follow Us
Hikma Pharmaceuticals PLC (GB:HIK)
LSE:HIK
RESEARCH TOOLSreports
Hikma Pharmaceuticals (HIK) Ownership Overview
The ownership structure of Hikma Pharmaceuticals (GB:HIK) stock is a mix of institutional, retail, and individual investors. , 7.66% is owned by Insiders, and 78.58% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 04, 2025 | Susan Ringdal Vice President | xxxxxxxxxxxxx | £90596 |
| Dec 23, 2024 | Susan Ringdal Vice President | xxxxxxxxxxxxx | £64251 |
| Aug 13, 2024 | Bassam Kanaan Chief Strategy Officer | xxxxxxxxxxxxx | £888498 |
| Mar 13, 2024 | Susan Ringdal Vice President | xxxxxxxxxxxxx | £156328 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,196,450 | Insider | 6.40% | 409,879,904 | |
| 6,963,687 | Institution | 3.14% | 201,055,571 | |
| 5,861,882 | Institution | 2.64% | 169,244,257 | |
| 2,256,463 | Institution | 1.02% | 65,148,600 | |
| 1,530,130 | Institution | 0.69% | 44,177,913 | |
| 1,381,071 | Institution | 0.62% | 39,874,282 | |
| 1,353,721 | Insider | 0.61% | 39,084,633 | |
| 1,153,830 | Institution | 0.52% | 33,313,380 | |
| 915,356 | Institution | 0.41% | 26,428,158 | |
| 853,196 | Institution | 0.38% | 24,633,475 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,256,463 | Institution | 1.02% | 65,148,600 | |
| 1,381,071 | Institution | 0.62% | 39,874,282 | |
| 915,356 | Institution | 0.41% | 26,428,158 | |
| 853,196 | Institution | 0.38% | 24,633,475 | |
| 739,345 | Institution | 0.33% | 21,346,369 | |
| 569,463 | Institution | 0.26% | 16,441,536 | |
| 553,251 | Institution | 0.25% | 15,973,463 | |
| 501,019 | Institution | 0.23% | 14,465,421 | |
| 389,751 | Institution | 0.18% | 11,252,891 | |
| 294,959 | Institution | 0.13% | 8,516,056 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,277,328 | Institution | 1.03% | 56,777,884 | |
| 1,402,435 | Institution | 0.63% | 34,965,192 | |
| 1,038,887 | Institution | 0.47% | 30,527,150 | |
| 1,027,092 | Institution | 0.46% | 30,180,560 | |
| 543,172 | Institution | 0.24% | 15,960,824 | |
| 396,499 | Institution | 0.18% | 11,650,915 | |
| 395,603 | Institution | 0.18% | 7,884,368 | |
| 325,156 | Institution | 0.15% | 8,106,716 | |
| 313,162 | Institution | 0.14% | 9,177,207 | |
| 306,726 | Institution | 0.14% | 7,647,223 |
FAQ
Who Owns Hikma Pharmaceuticals PLC (GB:HIK)?
Currently, no data Available
What percentage of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by institutional investors?
Currently, no data Available
What percentage of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by retail investors?
According to the latest TipRanks data, approximately 78.58% of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by retail investors.
Who owns the most shares of Hikma Pharmaceuticals PLC (GB:HIK)?
Said Darwazah owns the most shares of Hikma Pharmaceuticals PLC (GB:HIK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.